Bursać, S., Prodan, Y., Pullen, N., Bartek, J. i Volarević, S. (2021). Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer. Trends in Cancer, 7. (1), 57-76. doi: 10.1016/j.trecan.2020.08.003
Bursać, Slađana, et al. "Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer." Trends in Cancer, vol. 7, br. 1, 2021, str. 57-76. https://doi.org/10.1016/j.trecan.2020.08.003
Bursać, Slađana, Ylenia Prodan, Nick Pullen, Jiri Bartek i Siniša Volarević. "Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer." Trends in Cancer 7, br. 1 (2021): 57-76. https://doi.org/10.1016/j.trecan.2020.08.003
Bursać, S., et al. (2021) 'Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer', Trends in Cancer, 7(1), str. 57-76. doi: 10.1016/j.trecan.2020.08.003
Bursać S, Prodan Y, Pullen N, Bartek J, Volarević S. Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer. Trends in Cancer [Internet]. 2021. [pristupljeno 21.08.2024.];7(1):57-76. doi: 10.1016/j.trecan.2020.08.003
S. Bursać, Y. Prodan, N. Pullen, J. Bartek i S. Volarević, "Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer", Trends in Cancer, vol. 7, br. 1, str. 57-76, 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:723535. [Citirano: 21.08.2024.]